News impact

TEVA· last 90 days

TEVA PHARMACEUTICAL-SP ADR

Backward-looking only. These statistics describe how the price moved after past news — nothing more. Sample sizes are small, market context differs every day, and past performance is not indicative of future results. See methodology and disclaimer.

Bullish news (sentiment ≥ 0.3)

2articles

Avg +24h: +0.96%
Avg +72h: +0.12%
Avg +7d: -2.24%

Neutral news (−0.3 to 0.3)

0articles

Avg +24h: —
Avg +72h: —
Avg +7d: —

Bearish news (sentiment ≤ −0.3)

0articles

Avg +24h: —
Avg +72h: —
Avg +7d: —

Per-event price reaction · 2 events

GlobalNewswire6/10/2026, 4:03:00 PM
Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy
Sentiment
0.70
Relevance
100%
+24h
+3.13%
+72h
+0.33%
+7d
-6.25%
GlobalNewswire4/29/2026, 10:30:00 AM
Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy
Sentiment
0.70
Relevance
100%
+24h
-1.22%
+72h
-0.08%
+7d
+1.78%

Not investment advice. See full disclaimer.